NCT00050986 2020-09-22Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma MultiformeM.D. Anderson Cancer CenterPhase 1/2 Completed55 enrolled 6 charts
NCT00335764 2018-07-02Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or GliosarcomaNational Cancer Institute (NCI)Phase 1/2 Completed92 enrolled 24 charts